Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Tirzepatide: Evidence Summary
Evidence summary for Tirzepatide across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to Tirzepatide overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| Weight loss (obesity) | Tier A | 7 | SURMOUNT trials demonstrated 20-26% body weight reduction |
| Type 2 diabetes | Tier A | 9 | SURPASS trials showed superior HbA1c reduction vs comparators |
| Heart failure with preserved EF | Tier B | 1 | SUMMIT trial showed improvement in heart failure symptoms |